Abstract
Heat shock protein 70 (HSP70) represents a major stress-inducible chaperone, holding considerable significance in regulating the proteostasis, mitochondrial homeostasis, and apoptosis in the injured nervous system. Acupuncture has shown neuroprotective effects in multiple models of neurological diseases, yet the role of HSP70 as a mechanistic link between acupuncture stimulation and neuronal protection has not been systematically clarified. To this end, current evidence on acupuncture-induced HSP70 regulation is hereby summarized, and its potential contribution to neuroprotection is accordingly discussed, with particular emphasis on mitochondrial preservation and anti-apoptotic signaling. Available studies suggest that acupuncture-associated HSP70 upregulation is linked to enhanced cellular stress adaptation, reduced oxidative injury, stabilization of Bcl-2 family-dependent mitochondrial integrity, inhibition of cytochrome c release and apoptosome formation, and suppression of downstream caspase activation. In addition to these intracellular effects, emerging evidence also uncovers the involvement of HSP70 in neuroinflammatory regulation and neuron-glia communication, suggesting its broader role in shaping the injured neural microenvironment. However, current evidence remains largely associative, leaving several key issues unresolved, including questions of causal necessity, cell-specific regulation, intercellular trafficking, and neuroimmune integration. Overall, HSP70 may represent a promising integrative mediator of acupuncture-induced neuroprotection, yet its precise mechanistic function still warrants further experimental validation.
Keywords: Heat shock protein 70, acupuncture, neuroprotection, mitochondria, apoptosis, neuroinflammation
Introduction
Neuronal apoptosis and defective post-injury repair constitute key pathological features across numerous neurological disorders, including ischemic stroke, spinal cord injury, and neurodegenerative diseases [1]. Cellular adaptation to these pathological stresses is critically regulated by heat shock proteins (HSPs), which maintain proteostasis and promote survival under damaging conditions [2-4]. Among them, HSP70, rapidly induced by oxidative and ischemic stress and exerting broad cytoprotective effects, has gained increasing attention [5]. Existing evidence indicates that HSP70 can stabilize mitochondrial homeostasis, interfere with caspase-related apoptotic signaling, and support axonal recovery. All these imply its central position in neuronal stress resistance and post-injury repair [6-10].
Acupuncture has shown promising neuroprotective effects in multiple models of neurological injury [11]. Beyond improving neural repair and attenuating apoptosis, acupuncture has been reported to modulate neuroendocrine-immune interactions while activating intracellular signaling pathways such as PI3K/Akt and MAPK [12-14]. However, these mechanistic observations remain fragmented, and the role of HSP70 as a potential mediator linking acupuncture stimulation to neuronal survival has not been sufficiently integrated.
Given the intimate relationship between mitochondrial dysfunction and intrinsic apoptosis, HSP70 may function as a plausible mechanistic bridge between acupuncture and neuroprotection [15]. Nevertheless, it remains poorly defined how much acupuncture-triggered HSP70 upregulation actually contributes to mitochondrial preservation and apoptosis inhibition. Consequently, this review examines current evidence on acupuncture-induced HSP70 regulation and discusses the potential involvement of HSP70 in neuroprotection through interconnected mitochondrial and anti-apoptotic mechanisms in neural injury models.
Structure and functions of HSP70
HSP70 is a highly conserved molecular chaperone that plays essential roles in protein quality control, cellular stress tolerance, and survival. The HSP70 family includes multiple isoforms distributed across distinct subcellular compartments, including the cytosol, endoplasmic reticulum, and mitochondria, where they perform overlapping yet context-dependent functions [16]. Structurally, canonical HSP70 proteins consist of an N-terminal nucleotide-binding domain (NBD, ~44 kDa), a conserved interdomain linker, and a C-terminal substrate-binding domain (SBD), which contains a β-sheet-rich substrate-binding pocket and an α-helical lid domain [17].
ATP binding and hydrolysis drive nucleotide-dependent conformational changes and allosteric coupling between the NBD and SBD. In the ATP-bound state, HSP70 assumes a more open conformation characterized by reduced substrate affinity, facilitating rapid substrate binding and release. ATP hydrolysis to ADP promotes lid closure over the substrate-binding pocket, thus strengthening and stabilizing substrate interaction [18]. These conformational transitions are fundamental to the chaperone cycle of HSP70. Figure 1 illustrates the allosteric transitions of HSP70.
Figure 1.
ATP-dependent allosteric cycle of HSP70. HSP70 undergoes conformational transitions during its ATPase cycle. In the ATP-bound state, NBD adopts an open conformation, promoting linker docking and a low-affinity substrate-binding state of the SBDβ. ATP hydrolysis induces closure of the SBDα lid, resulting in high-affinity substrate binding. Following ADP release, the SBD reopens, allowing substrate dissociation and resetting the chaperone cycle. This ATP-driven cycle enables HSP70 to maintain proteostasis by preventing protein misfolding.
The SBD (~25 kDa) comprises a β-sheet-rich SBDβ subdomain and an α-helical SBDα lid, which together regulate substrate specificity, binding stability, and residence duration [19]. The C-terminal region further confers isoform-specific properties, including differences in client recognition, subcellular localization, and co-chaperone interactions [20]. Conformational fluctuations of the lid domain govern substrate entry into the binding cleft, enabling HSP70 to engage a broad range of unfolded or misfolded peptide motifs [21-23]. HSP70 recognizes non-native polypeptides, prevents protein aggregation, facilitates refolding or triage for degradation, and thus maintains proteostasis [16,24]. These functions are particularly important in neurons, which are highly vulnerable to proteostatic disruption owing to their long lifespan, high metabolic demand, and susceptibility to oxidative stress.
The HSP70 cycle is under stringent regulation by co-chaperones. J-domain proteins of the HSP40 family stimulate ATP hydrolysis and recruit client proteins to HSP70 [25,26]. By contrast, the BAG family proteins and HSPBP1 act as nucleotide exchange factors (NEFs), promoting ADP release and ATP rebinding to accelerate substrate cycling and influence client fate [24,27]. HSP110 family proteins likewise serve as nucleotide exchange factors for cytoplasmic HSP70 and contribute to the formation of large chaperone complexes that sustain protein quality control during acute proteotoxic stress [28,29]. The composition and activity of these co-chaperone systems are context-dependent, varying according to substrate load, stress intensity, and subcellular environment. In addition, post-translational modifications and isoform-specific sequence variations can modulate ATPase activity, client binding, intracellular localization, and chaperone stability, thus fine-tuning HSP70 functions [16,30]. Recent structural and computational studies verify a dynamic and heterogeneous mode of client engagement, consistent with a “fuzzy binding” model rather than a single static interaction interface [19,31].
In the nervous system, HSP70 undergoes rapid upregulation in response to acute pathological stressors, including oxidative stress, excitotoxicity, and mitochondrial dysfunction, thus promoting neuronal resilience [32-34]. As a key neuroprotective factor, HSP70 suppresses protein aggregation, assists protein folding, and limits stress-induced apoptosis [35]. Dysregulation of HSP70 and its co-chaperone network has been implicated in multiple neurological disorders, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and ischemic neuronal injury [35-37]. Therapeutic strategies under investigation include upregulating HSP70 expression, tuning co-chaperone activity, pharmacologically targeting allosteric regulation of the HSP70 cycle, and exploring combinatorial regimens aimed at selectively strengthening HSP70-dependent proteostasis [37,38].
Neuronal apoptosis and its regulatory mechanisms
Apoptosis is an energy-dependent form of programmed cell death under strict genetic control, which is essential for tissue homeostasis by removing damaged, impaired, or redundant cells [39,40]. In the nervous system, apoptosis assumes both physiological and pathological roles. Under physiological conditions, apoptosis contributes to neuronal development, circuit refinement, and the removal of supernumerary or damaged cells [41,42]. Conversely, excessive or dysregulated apoptosis results in irreversible neuronal loss in a wide range of neurological disorders, including ischemic stroke, Alzheimer’s disease, and Parkinson’s disease [43-45]. Due to their high metabolic demand, long lifespan, and limited regenerative capacity, neurons are especially prone to apoptotic injury [46], making it important to elucidate the molecular mechanisms of neuronal apoptosis for understanding disease progression and identifying potential neuroprotective strategies.
Apoptotic signaling is generally classified into two major pathways: the intrinsic (mitochondria-dependent) pathway and the extrinsic (death receptor-mediated) pathway. While initiated by distinct upstream signals, both pathways converge on the activation of executioner caspases, including caspase-3, -6, and -7, which dismantle cellular architecture and execute apoptotic cell death [47]. In neurons, the intrinsic pathway is particularly vital, as ischemia, excitotoxicity, oxidative stress, and calcium dysregulation frequently converge on mitochondrial dysfunction [48]. Conversely, the extrinsic pathway is closely linked to neuroinflammatory signaling, particularly in the presence of cytokines and death ligands released by activated glial cells [49].
Intrinsic (mitochondria-dependent) apoptotic pathway
The intrinsic pathway is triggered by intracellular stressors commonly observed in neural injury, including DNA damage, oxidative stress, calcium overload, and endoplasmic reticulum stress [50,51]. A central event in this pathway is mitochondrial outer membrane permeabilization (MOMP), which triggers the release of pro-apoptotic factors such as cytochrome c and Smac/DIABLO from the mitochondrial intermembrane space into the cytosol [52,53]. Cytosolic cytochrome c binds to apoptotic protease activating factor-1 (Apaf-1), promoting apoptosome formation and the activation of caspase-9. This initiates a cascade that activates effector caspases including caspase 3 and caspase 7, ultimately executing apoptotic cell death [47,54].
Neurons’ susceptibility to intrinsic apoptosis is strongly influenced by the balance among Bcl-2 family proteins [55]. Increased activation of pro-apoptotic proteins such as Bax and reduced expression or function of anti-apoptotic proteins such as Bcl-2 have been reported in cerebral ischemia, spinal cord injury, and neurodegenerative diseases [56,57]. Following MOMP, cytochrome c promotes apoptosome assembly, whereas Smac/DIABLO antagonizes XIAP and other inhibitor of apoptosis proteins (IAPs), thus relieving caspase suppression [58]. Dependent on oxidative phosphorylation, neurons are particularly sensitive to mitochondrial injury, creating a vicious cycle in which mitochondrial dysfunction amplifies apoptotic signaling, while apoptotic signaling further exacerbates mitochondrial damage [59,60].
Extrinsic (death receptor-mediated) apoptotic pathway
The extrinsic pathway is initiated by the activation of cell-surface death receptors, particularly members of the TNF receptor superfamily, including Fas (CD95), TNFR1, and the TRAIL receptors DR4 and DR5 [61,62]. These receptors are expressed by neurons and glial cells in the central nervous system and are closely linked to inflammatory signaling [63,64]. Upon ligand binding by FasL, TNF-α, or TRAIL, the receptors trimerize and recruit the adaptor protein FADD and pro-caspase-8 to form the death-inducing signaling complex (DISC) [65,66]. Subsequently, pro-caspase-8 is activated by autocatalytic cleavage, thereby initiating the downstream caspase cascade and apoptotic execution [67,68].
The intrinsic and extrinsic pathways are functionally connected through Bid, a BH3-only member of the Bcl-2 family. Activated caspase-8 cleaves Bid to generate truncated Bid (tBid), which translocates to mitochondria and promotes Bax/Bak-dependent mitochondrial permeabilization [69]. In this way, extrinsic death receptor signaling amplifies the intrinsic apoptotic pathway. This crosstalk is particularly evident in ischemic and inflammatory conditions where glia-derived TNF-α or FasL can activate death receptor signaling while simultaneously enhancing mitochondrial vulnerability, thereby accelerating neuronal death [70,71]. TNFR1 signaling is often regarded as a double-edged pathway. One branch activates NF-κB-dependent survival and inflammatory programs, whereas the other promotes caspase-8 activation and apoptotic cell death [72].
Overall, neuronal apoptosis arises from the integrated activation of both intrinsic and extrinsic signaling pathways, which converge on executioner caspases and ultimately give rise to irreversible neuronal damage. The intrinsic pathway is particularly relevant to ischemia, oxidative stress, calcium overload, and mitochondrial dysfunction, while the extrinsic pathway is closely associated with neuroinflammatory signaling. Given that excessive apoptosis is a hallmark pathological feature in many central nervous system diseases, regulatory molecules targeting both apoptotic pathways have attracted substantial research attention. In this context, HSP70 has emerged as a potentially important neuroprotective factor, as it may preserve mitochondrial integrity, interfere with apoptosome-related signaling, and limit death receptor-associated apoptotic activation. Collectively, these observations provide a mechanistic rationale for examining the contribution of HSP70’s acupuncture-mediated regulation to neuroprotection in neural injury.
Integration of apoptotic pathways and relevance to neuroprotection
In the injured nervous system, neuronal apoptosis rarely results from the isolated activation of a single pathway; instead, mitochondrial dysfunction, oxidative stress, inflammatory signaling, and death receptor activation often occur simultaneously and interact with one another, creating a self-amplifying pro-death environment [73]. Under these conditions, the distinction between intrinsic and extrinsic apoptosis remains mechanistically useful, yet the two pathways are better understood as interconnected components of a broader injury response. This very interplay holds critical implications for neuroprotection. In multiple neurological disorders, limiting neuronal death may depend not only on suppressing downstream caspase activation, but also on stabilizing mitochondrial function, reducing inflammatory amplification, and preserving intracellular stress tolerance [74,75]. Molecules acting at the interface of these processes are therefore of particular interest, as they may simultaneously affect several levels of the apoptotic cascade.
In this respect, HSP70 is of notable relevance because its protective roles are not limited to protein folding alone. Under stress conditions, HSP70 has been implicated in the maintenance of mitochondrial integrity, the regulation of apoptosome-associated signaling, and the attenuation of death receptor-related apoptosis [33]. Such actions suggest that HSP70 may contribute to neuronal survival by buffering the convergence of multiple injurious signals rather than by acting exclusively on a single apoptotic event. This integrative role may be especially important in pathological settings characterized by the coexistence of mitochondrial damage and inflammatory signaling, as is often the case in ischemic and neurodegenerative injury.
Viewed in this way, neuroprotection is not simply a matter of blocking apoptosis at its endpoint, but an issue of modulating the stress networks that drive neurons toward irreversible death. This facilitates a useful framework for considering how interventions that regulate HSP70 might influence neuronal fate under pathological conditions.
Role of HSP70 in regulating apoptosis
HSP70 regulates apoptosis at multiple levels and exerts potent cytoprotective effects. As a molecular chaperone, HSP70 inhibits Bax translocation to the outer mitochondrial membrane, limits cytochrome c release, and thereby attenuates apoptosome assembly and downstream caspase activation [33,76]. Additionally, HSP70 has been reported to interact with Apaf-1, thereby suppressing procaspase-9 activation, while also suppressing the activation of executioner caspases such as caspase-3 and caspase-7 [77]. HSP70 also attenuates AIF-mediated nuclear damage and modulates upstream stress pathways including death receptor signaling, protein kinase R (PKR), and lysosomal membrane permeabilization [78-80]. Taken together, these properties allow HSP70 to suppress both mitochondrial and receptor-mediated apoptotic signaling at multiple stages (Figure 2).
Figure 2.
Anti-apoptotic mechanisms of HSP70 in intrinsic and extrinsic apoptotic pathways. HSP70 interferes with multiple checkpoints of apoptosis. In the intrinsic pathway, HSP70 stabilizes Bcl-2 family proteins, inhibits Bax/Bak activation, prevents MOMP, and reduces cytochrome c release. HSP70 also binds Apaf-1 (Inset 1), thereby inhibiting apoptosome formation and caspase-9 activation. In the extrinsic pathway, HSP70 suppresses DISC formation, inhibits caspase-8 activation, and limits tBID-mediated mitochondrial amplification. In addition, HSP70 prevents AIF nuclear translocation (Inset 2), thereby attenuating caspase-independent cell death.
Conversely, loss or inhibition of HSP70 increases cellular susceptibility to apoptosis. This is accompanied by an increased Bax/Bcl-2 ratio, elevated cytosolic cytochrome c levels, and enhanced cleavage of caspase-3 and PARP1 [81]. Within the nervous system, the cytoprotective properties of HSP70 assume critical significance under pathological conditions such as ischemic injury, neurodegenerative diseases, and traumatic injury. Enhanced expression of HSP70 has been consistently linked to enhanced neuronal survival outcomes.
HSP70 in the intrinsic pathway
Within the intrinsic apoptotic pathway, HSP70 acts at multiple stages surrounding MOMP to limit death signaling. At the level of Bcl-2 family regulation, HSP70 stabilizes anti-apoptotic Bcl-2 while suppressing mitochondria-dependent apoptotic signaling [82]. HSP70 may also cooperate with anti-apoptotic proteins such as Bcl-2 and Bcl-XL to reinforce their pro-survival functions [83]. Under severe stress, Bax is activated and translocates to the mitochondrial outer membrane to drive MOMP, and HSP70 counteracts this process by inhibiting Bax translocation and oligomerization, thus limiting cytochrome c release [82,84,85]. In addition, HSP70 can directly interact with Apaf-1 and interfere with apoptosome assembly [86]. Mechanistically, the ATPase domain of HSP70 is indispensable for mediating its interactions with pro-apoptotic factors including Bax, thereby modulating the structural integrity of the mitochondrial membrane [87]. Through these coordinated actions, HSP70 preserves mitochondrial integrity and prevents the amplification of apoptotic signaling. These effects are particularly critical in neurons highly dependent on mitochondrial function and especially vulnerable to oxidative stress and energy failure [88].
HSP70 in the extrinsic pathway
HSP70 acts as an important modulator of the extrinsic apoptotic pathway. It can negatively regulate Fas at the protein level, thereby modulating Fas-related signaling [89]. Meanwhile, HSP70 suppresses Fas-mediated apoptosis by inhibiting caspase-8 activation, with a concomitant reduction in downstream caspase-3 activity [90]. In the TRAIL branch, HSP70 resists Apo-2L/TRAIL-induced apoptosis by associating with death receptors DR4 and DR5 and blocking recruitment of FADD and caspase-8 to the DISC, inhibiting DISC assembly and downstream apoptotic signaling [91]. More broadly, it dampens proteolytic signaling associated with receptor-mediated cell death [92].
Beyond receptor-proximal regulation, HSP70-associated molecules may also participate in TNFR-related death signaling under specific conditions. An HSP70-containing complex interacts with TNFR1 while inducing TNFR1-dependent cytotoxic signaling in tumor cells [93]. In addition, by binding IKKγ and impairing NF-κB-dependent survival signaling, HSP70 modulates TNF-associated downstream signaling, thus shifting the balance toward TNF-mediated apoptosis [94]. Importantly, it integrates intracellular and extracellular stress signals to restrain both major apoptotic pathways. Upon activation, caspase-8 cleaves Bid to generate truncated Bid (tBid). This fragment translocates to mitochondria and promotes mitochondrial outer membrane permeabilization, establishing a functional connection between death receptor signaling and the intrinsic apoptotic machinery [95-97]. Such a Bid-dependent crosstalk is critical, as it amplifies receptor-mediated apoptotic signaling through mitochondrial dysfunction, enhanced cytochrome c release, and downstream caspase activation [98-100]. By preserving mitochondrial integrity and restraining this Bid/tBid-mediated amplification loop, HSP70 limits the propagation of extrinsic apoptotic signals into the intrinsic pathway [91,101]. In certain type II cells, however, it may also modulate TRAIL sensitivity in a context-dependent manner by upregulating TRAIL-R1 and TRAIL-R2 through a p53-associated mechanism [102].
Aberrant Fas and TNFR signaling can promote neuroinflammation and neuronal degeneration. In animal models of cerebral ischemia and spinal cord injury, elevated HSP70 levels are associated with a lower Bax/Bcl-2 ratio, reduced cleavage of caspase-3 and caspase-8, and fewer TUNEL-positive neurons, supporting its anti-apoptotic and neuroprotective effects [89,90,103].
Acupuncture regulation of HSP70 in neuroprotection
In neurological disorders, acupuncture is increasingly recognized as a neuroprotective intervention. Among molecular mediators implicated in this process, HSP70 appears to be a key stress-responsive effector [80,104]. As a core component of the cellular stress response, it contributes to proteostasis, preserves mitochondrial integrity and function, and limits apoptosis triggered by ischemia, oxidative stress, inflammation, and excitotoxicity [105,106]. Experimental studies further indicate that acupuncture increases HSP70 expression in ischemia-affected brain regions, including the hippocampus and cerebral cortex, and that this HSP70 upregulation may improve neuronal tolerance to ischemic stress [107-110].
Mechanistically, the neuroprotective effects of acupuncture appear to converge on HSP70 through two closely related processes. First, acupuncture enhances stress adaptation through neuroendocrine regulation and activation of molecular chaperone responses [111], thereby favoring HSP70-associated resistance to oxidative and inflammatory injury [33]. Second, acupuncture may strengthen HSP70-associated mitochondrial protection by stabilizing Bcl-2-related survival signaling, limiting mitochondrial membrane permeabilization, and suppressing apoptotic signaling [112,113]. Collectively, these findings establish a mechanistic framework for interpreting the regulation of HSP70 by acupuncture in relation to neuronal survival and injury-related cellular responses.
Acupuncture-induced HSP70 upregulation and stress adaptation in neural injury
HSP70 is a major stress-responsive molecular chaperone involved in neuroprotection. In the injured central nervous system featuring limited regenerative capacity, inducible HSP70 facilitates the preservation of proteostasis, limit protein aggregation, and support neuronal survival under ischemic, oxidative, and inflammatory stress conditions [104,114]. Experimental studies indicate that acupuncture can upregulate HSP70 expression in injured or stress-sensitive brain tissue, and this induction is found to be generally associated with enhanced cellular stress adaptation, neuroprotection, and functional recovery under conditions such as cerebral ischemia/reperfusion injury [108-110,115]. Far from being a nonspecific stress response alone, this response appears to reflect an adaptive program through which peripheral somatic stimulation engages central stress-defense mechanisms.
A critical component of this adaptive response may involve neuroendocrine regulation through the hypothalamic-pituitary-adrenal (HPA) axis. Prolonged stress disrupts HPA negative feedback, while acupuncture may facilitate stress adaptation not only through HSP70-related cytoprotection but also through restoration of glucocorticoid receptor (GR)-dependent HPA-axis negative feedback, including increased GR expression in the hippocampus and hypothalamic PVN as well as reduced corticotropin-releasing hormone (CRH)/stimulates adrenocorticotropic hormone (ACTH) overactivation [116,117]. This observation is mechanistically relevant as GR folding, ligand responsiveness, and maturation depend on the HSP70 chaperone cycle and its cooperation with HSP90 [118]. Thus, acupuncture-induced HSP70 upregulation may promote stress adaptation not only by increasing the pool of available molecular chaperones, but also by supporting GR-dependent neuroendocrine homeostasis. Consistent with this view, electroacupuncture has also been demonstrated to concomitantly increase HSP72 expression and ACTH release. This supports the notion that acupuncture can engage both heat-shock-related cytoprotection and HPA-axis neuroendocrine activation as coordinated components of an adaptive stress response [110,119]. The neuroendocrine mechanism linking acupuncture stimulation to HSP70 upregulation via the HPA axis is illustrated in Figure 3.
Figure 3.
Acupuncture-mediated activation of the HPA axis and glucocorticoid receptor-dependent induction of HSP70. Acupuncture stimulation at acupoints (e.g., GV20, CV4, ST36, SP6) engages neural and humoral pathways that converge on the hypothalamus. HPA corticotropin-releasing hormone axis promotes CRH release, ACTH secretion from the pituitary, and induces cortisol production in the adrenal cortex. Cortisol binds to glucocorticoid receptors (GR), leading to GR nuclear translocation and upregulation of HSP70 transcription. This pathway links peripheral acupuncture stimulation to central stress adaptation and cytoprotective responses.
Regional induction of HSP70 following acupuncture is particularly pronounced in models of ischemic and excitotoxic brain injury. In cerebral ischemia-reperfusion models, electroacupuncture at GV26, PC9, and GV16 has been reported to further enhance HSP70 expression in the hippocampus, increase SOD activity, and reduce the MDA content in brain tissues. This suggests a potential association between HSP70 induction and protection against ischemia-reperfusion injury [109]. In middle cerebral artery occlusion models, electroacupuncture likewise increases HSP70 expression in ischemic cortical and hippocampal regions and is associated with reduced DNA fragmentation, lower PARP activation, and less apoptosis [108,120]. At the systems level, these findings suggest that acupuncture-induced HSP70 is not merely a marker of cellular stress, but may actively mediate regional adaptive responses to stress and early inflammatory remodeling following neural injury. This interpretation is further supported by observations that upon peripheral acupuncture stimulation, TRPV1-related somatosensory signaling may contribute to remote HSP70 induction in central stress-responsive regions [110,121]. While current evidence does not yet define the precise cell-specific origin of induced HSP70, available data support the view that acupuncture-evoked HSP70 upregulation is closely linked to adaptive stress resistance in the injured nervous system.
HSP70-associated mitochondrial protection and anti-apoptotic signaling after acupuncture
Neurons are characterized by their high energy demand, dependence on oxidative phosphorylation, and limited regenerative capacity, rendering them particularly vulnerable to mitochondrial dysfunction. In ischemia, excitotoxicity, and inflammatory injury, mitochondria-dependent apoptosis is rapidly activated and contributes substantially to neuronal loss in stroke, neurodegenerative disorders, traumatic brain injury, and spinal cord injury. Key events in this process encompass MOMP, pathological opening of the mitochondrial permeability transition pore (mPTP), and release of cytochrome c and apoptosis-inducing factor (AIF), which jointly govern the fate of stressed neurons toward either recovery or irreversible cell death. In this context, available evidence suggests that acupuncture-associated HSP70 upregulation is linked to reduced neuronal apoptosis and improved mitochondrial resilience [103,115].
A primary mechanism underlying the cytoprotective action of HSP70 involves the stabilization of Bcl-2 family-dependent mitochondrial homeostasis. HSP70 is known to preserve anti-apoptotic Bcl-2 signaling while limiting Bax activation, mitochondrial translocation, and oligomerization, thus restraining MOMP and cytochrome c release [74-76,87]. In cerebral ischemia models, electroacupuncture increases HSP70 and Bcl-2 expression in hippocampal and cortical neurons, while reducing Bax levels. These variations are accompanied by lower cytochrome c release and reduced caspase-3 activation [108-110]. In parallel, acupuncture improves oxidative balance by enhancing superoxide dismutase activity, reducing malondialdehyde accumulation, and preserving mitochondrial membrane potential in ischemic brain tissue [107]. These findings indicate that acupuncture-evoked HSP70 upregulation is closely associated with early mitochondrial stabilization, suppression of oxidative injury, and attenuation of intrinsic apoptotic signaling. Supportive evidence from non-acupuncture models further reinforces this interpretation: elevated HSP70 expression limits cytochrome c release, maintains mitochondrial transmembrane potential, and improves cell survival under oxidative stress. Conversely, reduced HSP70 levels correspond with Bax activation, membrane potential collapse, and apoptotic cell death [74-76,82,87,119].
Beyond these early events, acupuncture-associated HSP70 induction may also exert broader beneficial effects on mitochondrial quality control and cellular antioxidant systems. In ischemic and degenerative models, increased HSP70 expression is accompanied by improved mitochondrial morphology, reduced oxidative damage, and enhanced resistance of neurons to metabolic stress [94,95,99,105]. For instance, electroacupuncture increases spinal cord HSP70 expression in amyotrophic lateral sclerosis models and is associated with reduced oxidative injury and delayed functional decline [115]. Other acupuncture-responsive antioxidant pathways, including thioredoxin-1 and HIF-1α-related adaptive signaling, may cooperate with HSP70-associated cytoprotection rather than functioning as independent protective mechanisms [100,101]. Likewise, emerging evidence that acupuncture modulates mitochondrial quality control and mitophagy suggests an additional layer that reinforces HSP70-linked mitochondrial preservation, yet direct causal evidence for HSP70 dependence in these pathways remains limited [102,115,116].
At later stages of the intrinsic apoptotic cascade, HSP70-associated protection may extend to inhibition of mPTP opening, restraint of AIF translocation, and suppression of apoptosome-dependent caspase activation. Pathological opening of the mPTP causes rapid dissipation of mitochondrial membrane potential, swelling of mitochondria, rupture of the outer membrane, and release of cytochrome c and AIF; once translocated to the nucleus, AIF induces large-scale DNA fragmentation through a caspase-independent mechanism particularly relevant in severe ischemia-reperfusion injury [92,102]. In myocardial ischemia-reperfusion models, electroacupuncture pretreatment inhibits FXR/SHP signaling, upregulates HSP70, and reduces AIF translocation [122], supporting the possibility that HSP70 contributes to controlling mPTP-dependent death pathways. In central nervous system ischemia models, acupuncture preserves mitochondrial membrane potential, mitigates mitochondrial swelling, reduces cytosolic release of pro-apoptotic factors, and attenuates caspase-9 and caspase-3 activation [92,98,103,107]. Mechanistically, this pattern is consistent with the established anti-apoptotic functions of HSP70, including interference with Apaf-1-dependent apoptosome assembly and inhibition of downstream caspase activation [92,120]. Additional acupuncture studies have demonstrated reduced Bax, caspase-9, caspase-3, and TUNEL positivity after preconditioning, which further support the view that acupuncture-evoked HSP70 may restrain apoptosis both upstream at the mitochondrial level and downstream at the level of apoptosome and effector caspases [116,117,121]. Taken together, current evidence supports a model wherein acupuncture-associated HSP70 induction stabilizes mitochondria, mitigates oxidative injury, and suppresses both caspase-dependent and caspase-independent apoptotic execution, thus facilitating neuronal survival following stress.
Neuroinflammatory and cellular contexts of acupuncture-induced HSP70 regulation
Beyond its intracellular anti-apoptotic functions, HSP70 also regulates the neuroinflammatory processes and cellular interactions within the central nervous system [123]. As a chaperokine, extracellular HSP70 serves as both a molecular chaperone and a signaling regulator, interacting with cell surface receptors including TLR4 and RAGE to activate diverse pathways that modulate neuroinflammation and glial cell communication [124-126]. Accumulating evidence suggests that the neuroprotective effects of acupuncture-induced HSP70 are not solely attributable to intracellular mechanisms, but also involve complex interactions among neurons, glial cells, and the immune microenvironment [127-129].
Among these cellular components, microglia play a pivotal regulatory role by engaging in complex crosstalk with neurons, astrocytes, oligodendrocytes, and infiltrating immune cells. They secrete pro-inflammatory mediators and chemokines that actively remodel the neuroinflammatory microenvironment following neural injury [130,131]. Activated microglia can adopt distinct phenotypes, broadly categorized as pro-inflammatory (M1-like) and anti-inflammatory (M2-like) states, each exerting differential effects on neuronal survival [132]. An imbalance between these phenotypic states is closely linked to neurodegenerative processes. HSP70 has been reported to suppress pro-inflammatory signaling pathways and may promote a shift toward a more neuroprotective microglial phenotype [133,134]. In addition to microglia, astrocytes contribute to neuronal protection by maintaining metabolic support, regulating extracellular homeostasis, and modulating inflammatory responses [135]. Acupuncture-induced HSP70 expression in astrocytes may further enhance these supportive functions while attenuating inflammatory stress within the neural microenvironment [136-138].
Beyond its cell-autonomous effects, accumulating evidence suggests that HSP70 may also play a role in intercellular communication within the central nervous system [15]. It can be released into the extracellular space through non-classical secretion pathways, including exosome-mediated transport [139]. Specifically, astrocyte-derived exosomes containing HSP70 are internalized by neurons, leading to enhanced neuronal stress tolerance and survival [140]. However, it remains unclear whether acupuncture-induced HSP70 is transferred between glial cells and neurons through such mechanisms. Additional studies are required to determine whether HSP70-mediated neuron-glia communication contributes to the overall neuroprotective effects of acupuncture.
At the systems level, these intracellular and intercellular mechanisms converge to form a coordinated protective network. HSP70 preserves mitochondrial integrity, restricts mitochondrial permeability transition, reduces AIF release, and suppresses apoptosome formation and caspase activation. These effects are further reinforced by the modulation of neuroinflammatory responses and cellular interactions, thus inhibiting the amplification of oxidative stress and apoptotic signaling. Taken together, HSP70 functions as a pivotal mediator that bridges acupuncture-induced signals with mitochondrial preservation, inflammation control, and neuronal survival.
Discussion
While growing evidence associates acupuncture-induced HSP70 expression with attenuated neuronal damage and apoptosis, current studies remain constrained by several notable limitations that hinder mechanistic interpretation. The major unresolved issues can be broadly grouped into three areas: causal inference, cell-specific regulation, and systems-level neuroimmune integration. First, most available studies show an association between HSP70 upregulation and improved outcomes, yet they fail to establish whether HSP70 is mechanistically required for acupuncture-induced neuroprotection. In particular, loss-of-function experiments and cell-specific intervention studies remain scarce in acupuncture models, making it challenging to distinguish whether HSP70 is a true effector or merely a stress-associated marker. Second, current evidence lacks sufficient cell-specific resolution to clarify the location, timing, and mechanism of HSP70 induction following acupuncture stimulation. While HSP70 upregulation has been reported in both neurons and glial cells, it is still unclear whether these responses occur synchronously, differ in magnitude, or reflect distinct functional roles in neuronal protection and inflammatory regulation. These observations suggest that HSP70 is unlikely to act as a purely intracellular anti-apoptotic molecule, but may instead function in a cell-context-dependent manner across varying neural cell populations. Third, the intercellular trafficking and extracellular signaling of HSP70 within the injured nervous system remain poorly defined. A particularly important unresolved question is whether acupuncture-induced HSP70 can be transferred between glial cells and neurons through extracellular vesicles, including exosome-mediated pathways. It also remains uncertain whether HSP70 contributes to broader neuroimmune regulation following acupuncture, including blood-brain barrier stability [141], peripheral immune-cell recruitment [142], and T-cell-associated inflammatory responses [143].
Whether the immunomodulatory properties of HSP70 induced by acupuncture are restricted solely to microglial modulation or also participate in shaping adaptive immune responses still awaits further clarification. One possible explanation is that HSP70 may influence not only microglial polarization, but also the local neuroinflammatory environment, indirectly affecting processes such as the Th17/Treg balance [144]. Another outstanding question is whether varying acupuncture parameters produce distinct temporal or quantitative patterns of HSP70 induction. Importantly, parameter-dependent variations in HSP70 induction may help account for the inconsistent effects of acupuncture on microglial activation, cytokine profiles, and peripheral immune-cell responses across experimental settings. Future studies should therefore prioritize systematic comparisons of stimulation modality, frequency, intensity, treatment timing, and acupoint selection, while simultaneously assessing cell-specific HSP70 induction, intercellular signaling, and downstream inflammatory outcomes. Resolving these limitations will be essential not only to establish whether HSP70 is mechanistically indispensable for the neuroprotective effects of acupuncture, but also to clarify its role as a central hub coordinating mitochondrial protection, glial regulation, and neuroimmune adaptation.
Disclosure of conflict of interest
None.
References
- 1.Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42:259–305. doi: 10.1002/med.21817. [DOI] [PubMed] [Google Scholar]
- 2.Daugaard M, Rohde M, Jäättelä M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett. 2007;581:3702–3710. doi: 10.1016/j.febslet.2007.05.039. [DOI] [PubMed] [Google Scholar]
- 3.Lang BJ, Guerrero ME, Prince TL, Okusha Y, Bonorino C, Calderwood SK. The functions and regulation of heat shock proteins; key orchestrators of proteostasis and the heat shock response. Arch Toxicol. 2021;95:1943–1970. doi: 10.1007/s00204-021-03070-8. [DOI] [PubMed] [Google Scholar]
- 4.Kumari B. Cellular stress responses and associated diseases: a focus on heat shock proteins. Cell Biochem Biophys. 2025;83:2793–2804. doi: 10.1007/s12013-025-01724-3. [DOI] [PubMed] [Google Scholar]
- 5.Zhao A, Zhang G, Wei H, Yan X, Gan J, Jiang X. Heat shock proteins in cerebral ischemia-reperfusion injury: Mechanisms and therapeutic implications. Exp Neurol. 2025;390:115284. doi: 10.1016/j.expneurol.2025.115284. [DOI] [PubMed] [Google Scholar]
- 6.Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction. PLoS Biol. 2010;8:e1000410. doi: 10.1371/journal.pbio.1000410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62:670–684. doi: 10.1007/s00018-004-4464-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rosenzweig R, Nillegoda NB, Mayer MP, Bukau B. The Hsp70 chaperone network. Nat Rev Mol Cell Biol. 2019;20:665–680. doi: 10.1038/s41580-019-0133-3. [DOI] [PubMed] [Google Scholar]
- 9.Bahr T, Katuri J, Liang T, Bai Y. Mitochondrial chaperones in human health and disease. Free Radic Biol Med. 2022;179:363–374. doi: 10.1016/j.freeradbiomed.2021.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Havalová H, Ondrovičová G, Keresztesová B, Bauer JA, Pevala V, Kutejová E, Kunová N. Mitochondrial HSP70 chaperone system-the influence of post-translational modifications and involvement in human diseases. Int J Mol Sci. 2021;22:8077. doi: 10.3390/ijms22158077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shang WY, Ren YF, Huang J, Li B, Huang XM, Zhang ZL. Progress of researches on acupuncture treatment of spinal cord injury by promoting axonal regeneration. Zhen Ci Yan Jiu. 2025;50:96–103. doi: 10.13702/j.1000-0607.20230840. [DOI] [PubMed] [Google Scholar]
- 12.Xue X, You Y, Tao J, Ye X, Huang J, Yang S, Lin Z, Hong Z, Peng J, Chen L. Electro-acupuncture at points of zusanli and quchi exerts anti-apoptotic effect through the modulation of PI3K/akt signaling pathway. Neurosci Lett. 2014;558:14–19. doi: 10.1016/j.neulet.2013.10.029. [DOI] [PubMed] [Google Scholar]
- 13.Li N, Guo Y, Gong Y, Zhang Y, Fan W, Yao K, Chen Z, Dou B, Lin X, Chen B, Chen Z, Xu Z, Lyu Z. The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation. J Inflamm Res. 2021;14:7191–7224. doi: 10.2147/JIR.S341581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Liu J, Zhang H, Huang G, Xu M, Zhang J, Yin X. Reviews on acupuncture for cellular signal transduction in spinal cord injury. Zhongguo Zhen Jiu. 2017;37:680–684. doi: 10.13703/j.0255-2930.2017.06.030. [DOI] [PubMed] [Google Scholar]
- 15.Belenichev IF, Aliyeva OG, Popazova OO, Bukhtiyarova NV. Involvement of heat shock proteins HSP70 in the mechanisms of endogenous neuroprotection: the prospect of using HSP70 modulators. Front Cell Neurosci. 2023;17:1131683. doi: 10.3389/fncel.2023.1131683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Radons J. The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones. 2016;21:379–404. doi: 10.1007/s12192-016-0676-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Mayer MP, Gierasch LM. Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones. J Biol Chem. 2019;294:2085–2097. doi: 10.1074/jbc.REV118.002810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wentink A, Rosenzweig R, Kampinga H, Bukau B. Mechanisms and regulation of the Hsp70 chaperone network. Nat Rev Mol Cell Biol. 2026;27:110–128. doi: 10.1038/s41580-025-00890-9. [DOI] [PubMed] [Google Scholar]
- 19.Rosenzweig R, Sekhar A, Nagesh J, Kay LE. Promiscuous binding by Hsp70 results in conformational heterogeneity and fuzzy chaperone-substrate ensembles. Elife. 2017;6:e28030. doi: 10.7554/eLife.28030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang H, Hu H, Wu S, Perrett S. Effect of evolution of the C-terminal region on chaperone activity of Hsp70. Protein Sci. 2023;32:e4549. doi: 10.1002/pro.4549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kityk R, Vogel M, Schlecht R, Bukau B, Mayer MP. Pathways of allosteric regulation in Hsp70 chaperones. Nat Commun. 2015;6:8308. doi: 10.1038/ncomms9308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rohland L, Kityk R, Smalinskaitė L, Mayer MP. Conformational dynamics of the Hsp70 chaperone throughout key steps of its ATPase cycle. Proc Natl Acad Sci U S A. 2022;119:e2123238119. doi: 10.1073/pnas.2123238119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chaari A, Saikia N, Paul P, Yousef M, Ding F, Ladjimi M. Experimental and computational investigation of the effect of Hsc70 structural variants on inhibiting amylin aggregation. Biophys Chem. 2024;309:107235. doi: 10.1016/j.bpc.2024.107235. [DOI] [PubMed] [Google Scholar]
- 24.O’Connor MS, Konovalov KA, Duvall JL, Jang J, Lao Y, Cavagnero S, Huang X. Role of Hsp70 chaperone in client-protein folding elucidated by Markov state modeling and NMR restraint-assisted molecular dynamics simulations. Biophys J. 2025 doi: 10.1016/j.bpj.2025.08.022. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol. 2010;11:579–592. doi: 10.1038/nrm2941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bascos NAD, Mayer MP, Bukau B, Landry SJ. The Hsp40 J-domain modulates Hsp70 conformation and ATPase activity with a semi-elliptical spring. Protein Sci. 2017;26:1838–1851. doi: 10.1002/pro.3223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Knapp RT, Wong MJ, Kollmannsberger LK, Gassen NC, Kretzschmar A, Zschocke J, Hafner K, Young JC, Rein T. Hsp70 cochaperones HspBP1 and BAG-1M differentially regulate steroid hormone receptor function. PLoS One. 2014;9:e85415. doi: 10.1371/journal.pone.0085415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Dragovic Z, Broadley SA, Shomura Y, Bracher A, Hartl FU. Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s. EMBO J. 2006;25:2519–2528. doi: 10.1038/sj.emboj.7601138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kumar V, Peter JJ, Sagar A, Ray A, Jha MP, Rebeaud ME, Tiwari S, Goloubinoff P, Ashish F, Mapa K. Interdomain communication suppressing high intrinsic ATPase activity of Sse1 is essential for its co-disaggregase activity with Ssa1. FEBS J. 2020;287:671–694. doi: 10.1111/febs.15045. [DOI] [PubMed] [Google Scholar]
- 30.Abrams JL, Verghese J, Gibney PA, Morano KA. Hierarchical functional specificity of cytosolic heat shock protein 70 (Hsp70) nucleotide exchange factors in yeast. J Biol Chem. 2014;289:13155–13167. doi: 10.1074/jbc.M113.530014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nordquist EB, Clerico EM, Chen J, Gierasch LM. Computationally-aided modeling of Hsp70-client interactions: past, present, and future. J Phys Chem B. 2022;126:6780–6791. doi: 10.1021/acs.jpcb.2c03806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zatsepina OG, Evgen’ev MB, Garbuz DG. Role of a heat shock transcription factor and the major heat shock protein hsp70 in memory formation and neuroprotection. Cells. 2021;10:1638. doi: 10.3390/cells10071638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kim JY, Barua S, Huang MY, Park J, Yenari MA, Lee JE. Heat shock protein 70 (HSP70) induction: chaperonotherapy for neuroprotection after brain injury. Cells. 2020;9:2020. doi: 10.3390/cells9092020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lai Y, Du L, Dunsmore KE, Jenkins LW, Wong HR, Clark RS. Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity. J Neurochem. 2005;94:360–366. doi: 10.1111/j.1471-4159.2005.03212.x. [DOI] [PubMed] [Google Scholar]
- 35.Ben Khalaf N. Heat shock proteins (Hsp70 and Hsp90) in neurodegeneration: pathogenic roles and therapeutic potential. Front Aging Neurosci. 2026;18:1711422. doi: 10.3389/fnagi.2026.1711422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, Prado VF, Prado MAM. The Hsp70/Hsp90 chaperone machinery in neurodegenerative diseases. Front Neurosci. 2017;11:254. doi: 10.3389/fnins.2017.00254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang L, Bergkvist L, Kumar R, Winblad B, Pavlov PF. Targeting chaperone/co-chaperone interactions with small molecules: a novel approach to tackle neurodegenerative diseases. Cells. 2021;10:2596. doi: 10.3390/cells10102596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Patury S, Miyata Y, Gestwicki JE. Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem. 2009;9:1337–1351. doi: 10.2174/156802609789895674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018;36:489–517. doi: 10.1146/annurev-immunol-042617-053010. [DOI] [PubMed] [Google Scholar]
- 40.Mustafa M, Ahmad R, Tantry IQ, Ahmad W, Siddiqui S, Alam M, Abbas K, Moinuddin, Hassan MI, Habib S, Islam S. Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications. Cells. 2024;13:1838. doi: 10.3390/cells13221838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yamaguchi Y, Miura M. Programmed cell death in neurodevelopment. Dev Cell. 2015;32:478–490. doi: 10.1016/j.devcel.2015.01.019. [DOI] [PubMed] [Google Scholar]
- 42.Geden MJ, Romero SE, Deshmukh M. Apoptosis versus axon pruning: molecular intersection of two distinct pathways for axon degeneration. Neurosci Res. 2019;139:3–8. doi: 10.1016/j.neures.2018.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cai W, Shen WD. Anti-apoptotic mechanisms of acupuncture in neurological diseases: a review. Am J Chin Med. 2018;46:515–535. doi: 10.1142/S0192415X1850026X. [DOI] [PubMed] [Google Scholar]
- 44.Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1:120–129. doi: 10.1038/35040009. [DOI] [PubMed] [Google Scholar]
- 45.Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029–2044. doi: 10.1038/s41418-021-00814-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Liu N, Liu Y, Wang Y, Feng C, Piao M, Liu M. Oxidative cell death in the central nervous system: mechanisms and therapeutic strategies. Front Cell Dev Biol. 2025;13:1562344. doi: 10.3389/fcell.2025.1562344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kashyap D, Garg VK, Goel N. Intrinsic and extrinsic pathways of apoptosis: role in cancer development and prognosis. Adv Protein Chem Struct Biol. 2021;125:73–120. doi: 10.1016/bs.apcsb.2021.01.003. [DOI] [PubMed] [Google Scholar]
- 48.Yusuf JA, Akanbi ST, Ijibadejo MS, Sulaiman SE, Olorunlowu DR, Akinola AO, Abe AP, Opoola EK, Adejobi EO, Adigun TD, Sulaiman YO, Abdulmalik NI, Kayode EA, Adeleye OO. A review of mitochondrial dysfunction, pathophysiology and therapeutic prospects in neurodegenerative diseases. Discover Neuroscience. 2025;20:25. [Google Scholar]
- 49.Malone K, LaCasse E, Beug ST. Cell death in glioblastoma and the central nervous system. Cell Oncol (Dordr) 2025;48:313–349. doi: 10.1007/s13402-024-01007-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39:BSR20180992. doi: 10.1042/BSR20180992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J. 2022;479:357–384. doi: 10.1042/BCJ20210854. [DOI] [PubMed] [Google Scholar]
- 52.Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11:621–632. doi: 10.1038/nrm2952. [DOI] [PubMed] [Google Scholar]
- 53.Peña-Blanco A, García-Sáez AJ. Bax, bak and beyond - mitochondrial performance in apoptosis. FEBS J. 2018;285:416–431. doi: 10.1111/febs.14186. [DOI] [PubMed] [Google Scholar]
- 54.Borgeaud AC, Ganeva I, Klein C, Stooss A, Ross-Kaschitza D, Wu L, Riley JS, Tait SWG, Lemmin T, Kaufmann T, Kukulski W. Large transient assemblies of Apaf1 constitute the apoptosome in cells. Nat Commun. 2025;16:9429. doi: 10.1038/s41467-025-64478-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Pemberton JM, Pogmore JP, Andrews DW. Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins. Cell Death Differ. 2021;28:108–122. doi: 10.1038/s41418-020-00654-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Nguyen D, Osterlund E, Kale J, Andrews DW. The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death. Biochem J. 2024;481:903–922. doi: 10.1042/BCJ20210352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kristiansen M, Ham J. Programmed cell death during neuronal development: the sympathetic neuron model. Cell Death Differ. 2014;21:1025–1035. doi: 10.1038/cdd.2014.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106–1121. doi: 10.1038/s41423-020-00630-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Rose J, Brian C, Woods J, Pappa A, Panayiotidis MI, Powers R, Franco R. Mitochondrial dysfunction in glial cells: implications for neuronal homeostasis and survival. Toxicology. 2017;391:109–115. doi: 10.1016/j.tox.2017.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, Lindsey JD, Wissinger B, Ellisman MH, Weinreb RN, Perkins GA, Ju WK. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2011;2:e240. doi: 10.1038/cddis.2011.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Green DR. The death receptor pathway of apoptosis. Cold Spring Harb Perspect Biol. 2022;14:a041053. doi: 10.1101/cshperspect.a041053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Diaz Arguello OA, Haisma HJ. Apoptosis-inducing TNF superfamily ligands for cancer therapy. Cancers (Basel) 2021;13:1543. doi: 10.3390/cancers13071543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008;5:45. doi: 10.1186/1742-2094-5-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Malone K, LaCasse E, Beug ST. Cell death in glioblastoma and the central nervous system. Cell Oncol (Dordr) 2025;48:313–349. doi: 10.1007/s13402-024-01007-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305–1308. doi: 10.1126/science.281.5381.1305. [DOI] [PubMed] [Google Scholar]
- 66.Annibaldi A, Walczak H. Death receptors and their ligands in inflammatory disease and cancer. Cold Spring Harb Perspect Biol. 2020;12:a036384. doi: 10.1101/cshperspect.a036384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Gupta S, Lopez MA, Ektesabi AM, Tsoporis JN, Vaswani CM, Gandhi SY, Fairn GD, Dos Santos CC, Marshall JC. Caspase-8: arbitrating life and death in the innate immune system. Cells. 2025;14:240. doi: 10.3390/cells14040240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Lavrik I, Krueger A, Schmitz I, Baumann S, Weyd H, Krammer PH, Kirchhoff S. The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell Death Differ. 2003;10:144–145. doi: 10.1038/sj.cdd.4401156. [DOI] [PubMed] [Google Scholar]
- 69.Seo J, Lee EW, Shin J, Seong D, Nam YW, Jeong M, Lee SH, Lee C, Song J. K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death. Oncogene. 2018;37:4994–5006. doi: 10.1038/s41388-018-0323-z. [DOI] [PubMed] [Google Scholar]
- 70.Fu TM, Li Y, Lu A, Li Z, Vajjhala PR, Cruz AC, Srivastava DB, DiMaio F, Penczek PA, Siegel RM, Stacey KJ, Egelman EH, Wu H. Cryo-EM structure of caspase-8 tandem DED filament reveals assembly and regulation mechanisms of the death-inducing signaling complex. Mol Cell. 2016;64:236–250. doi: 10.1016/j.molcel.2016.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Jiang Y, Yu M, Hu X, Han L, Yang K, Ba H, Zhang Z, Yin B, Yang XP, Li Z, Wang J. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1. Cell Death Differ. 2017;24:660–671. doi: 10.1038/cdd.2016.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Wertz IE. TNFR1-activated NF-κB signal transduction: regulation by the ubiquitin/proteasome system. Curr Opin Chem Biol. 2014;23:71–77. doi: 10.1016/j.cbpa.2014.10.011. [DOI] [PubMed] [Google Scholar]
- 73.Liu T, Kong X, Qiao J, Wei J. Decoding Parkinson’s disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations. Redox Biol. 2025;85:103787. doi: 10.1016/j.redox.2025.103787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Volonté C, Hu G, Shaw CA, Viegas C, Santos JAd, Vaz SH, Sebastião AM, Balcar VJ, Mozley PD, Verde F, Silani V, Viero FT, Tang Y, Ulrich H, Franco R. Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases. Explor Neuroprotective Ther. 2026;6:1004136. [Google Scholar]
- 75.Tucker D, Lu Y, Zhang Q. From mitochondrial function to neuroprotection-an emerging role for methylene blue. Mol Neurobiol. 2018;55:5137–5153. doi: 10.1007/s12035-017-0712-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Gotoh T, Terada K, Oyadomari S, Mori M. hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of bax to mitochondria. Cell Death Differ. 2004;11:390–402. doi: 10.1038/sj.cdd.4401369. [DOI] [PubMed] [Google Scholar]
- 77.Su Y, Zheng X. HSP70-mediated autophagy-apoptosis-inflammation network and neuroprotection induced by heat acclimatization. Biology (Basel) 2025;14:774. doi: 10.3390/biology14070774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Kim JY, Han Y, Lee JE, Yenari MA. The 70-kDa heat shock protein (Hsp70) as a therapeutic target for stroke. Expert Opin Ther Targets. 2018;22:191–199. doi: 10.1080/14728222.2018.1439477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun. 2010;2:238–247. doi: 10.1159/000296508. [DOI] [PubMed] [Google Scholar]
- 80.Singh MK, Han S, Ju S, Ranbhise JS, Ha J, Yeo SG, Kim SS, Kang I. Hsp70: a multifunctional chaperone in maintaining proteostasis and its implications in human disease. Cells. 2025;14:509. doi: 10.3390/cells14070509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Önay Uçar E, Şengelen A, Mertoğlu Kamalı E. Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells. Biochem Pharmacol. 2023;208:115409. doi: 10.1016/j.bcp.2022.115409. [DOI] [PubMed] [Google Scholar]
- 82.Baechler BL, Bloemberg D, Quadrilatero J. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy. 2019;15:1606–1619. doi: 10.1080/15548627.2019.1591672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Ekici M, Ateş MB, Baş-Ekici H, Özgür A. Effect of dexpanthenol on cyclophosphamide-induced ovarian toxicity: a histological and molecular study in rats. Reprod Biomed Online. 2024;48:103778. doi: 10.1016/j.rbmo.2023.103778. [DOI] [PubMed] [Google Scholar]
- 84.Yang X, Wang J, Zhou Y, Wang Y, Wang S, Zhang W. Hsp70 promotes chemoresistance by blocking bax mitochondrial translocation in ovarian cancer cells. Cancer Lett. 2012;321:137–143. doi: 10.1016/j.canlet.2012.01.030. [DOI] [PubMed] [Google Scholar]
- 85.Wang Y, Abazid A, Badendieck S, Mustea A, Stope MB. Impact of non-invasive physical plasma on heat shock protein functionality in eukaryotic cells. Biomedicines. 2023;11:1471. doi: 10.3390/biomedicines11051471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Jahangirizadeh Z, Ghafouri H, Sajedi RH, Sariri R, Hossienkhani S. Rapid and simple screening of the apoptotic compounds based on Hsp70 inhibition using luciferase as an intracellular reporter. Anal Bioanal Chem. 2020;412:149–158. doi: 10.1007/s00216-019-02220-3. [DOI] [PubMed] [Google Scholar]
- 87.Jiang B, Wang K, Liang P, Xiao W, Wang H, Xiao X. ATP-binding domain of heat shock protein 70 is essential for its effects on the inhibition of the release of the second mitochondria-derived activator of caspase and apoptosis in C2C12 cells. FEBS J. 2009;276:2615–2624. doi: 10.1111/j.1742-4658.2009.06989.x. [DOI] [PubMed] [Google Scholar]
- 88.Song N, Mei S, Wang X, Hu G, Lu M. Focusing on mitochondria in the brain: from biology to therapeutics. Transl Neurodegener. 2024;13:23. doi: 10.1186/s40035-024-00409-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Guan D, Li Y, Cui Y, Guo Y, Dong N, Li G, Dai Y, Ji L. Down-regulated miR-374c and Hsp70 promote Th17 cell differentiation by inducing fas expression in experimental autoimmune encephalomyelitis. Int J Biol Macromol. 2020;154:1158–1165. doi: 10.1016/j.ijbiomac.2019.11.147. [DOI] [PubMed] [Google Scholar]
- 90.Zhao Y, Wang W, Qian L. Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting fas-mediated apoptosis. Cell Stress Chaperones. 2007;12:83–95. doi: 10.1379/CSC-231R.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Guo F, Sigua C, Bali P, George P, Fiskus W, Scuto A, Annavarapu S, Mouttaki A, Sondarva G, Wei S, Wu J, Djeu J, Bhalla K. Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. Blood. 2005;105:1246–1255. doi: 10.1182/blood-2004-05-2041. [DOI] [PubMed] [Google Scholar]
- 92.Kong F, Wang H, Guo J, Peng M, Ji H, Yang H, Liu B, Wang J, Zhang X, Li S. Hsp70 suppresses apoptosis of BRL cells by regulating the expression of bcl-2, cytochrome C, and caspase 8/3. In Vitro Cell Dev Biol Anim. 2016;52:568–575. doi: 10.1007/s11626-016-0005-5. [DOI] [PubMed] [Google Scholar]
- 93.Yashin DV, Ivanova OK, Soshnikova NV, Sheludchenkov AA, Romanova EA, Dukhanina EA, Tonevitsky AG, Gnuchev NV, Gabibov AG, Georgiev GP, Sashchenko LP. Tag7 (PGLYRP1) in complex with Hsp70 induces alternative cytotoxic processes in tumor cells via TNFR1 receptor. J Biol Chem. 2015;290:21724–21731. doi: 10.1074/jbc.M115.639732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Ran R, Lu A, Zhang L, Tang Y, Zhu H, Xu H, Feng Y, Han C, Zhou G, Rigby AC, Sharp FR. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 2004;18:1466–1481. doi: 10.1101/gad.1188204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491–501. doi: 10.1016/s0092-8674(00)81590-1. [DOI] [PubMed] [Google Scholar]
- 96.Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481–490. doi: 10.1016/s0092-8674(00)81589-5. [DOI] [PubMed] [Google Scholar]
- 97.Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675–1687. doi: 10.1093/emboj/17.6.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ, Petit PX, Vaz FM, Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol. 2008;183:681–696. doi: 10.1083/jcb.200803129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B, Diolez P, Manon S, Martinou JC, Goubern M, Wang X, Bernard S, Petit PX. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ. 2005;12:614–626. doi: 10.1038/sj.cdd.4401571. [DOI] [PubMed] [Google Scholar]
- 100.Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM, Gottlieb E. BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ. 2011;18:538–548. doi: 10.1038/cdd.2010.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Gabai VL, Mabuchi K, Mosser DD, Sherman MY. Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol Cell Biol. 2002;22:3415–3424. doi: 10.1128/MCB.22.10.3415-3424.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Clemons NJ, Anderson RL. TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression. Cell Stress Chaperones. 2006;11:343–355. doi: 10.1379/CSC-206.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Komarova EY, Afanasyeva EA, Bulatova MM, Cheetham ME, Margulis BA, Guzhova IV. Downstream caspases are novel targets for the antiapoptotic activity of the molecular chaperone hsp70. Cell Stress Chaperones. 2004;9:265–275. doi: 10.1379/CSC-27R1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Kampinga HH, Bergink S. Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol. 2016;15:748–759. doi: 10.1016/S1474-4422(16)00099-5. [DOI] [PubMed] [Google Scholar]
- 105.Matsumori Y, Northington FJ, Hong SM, Kayama T, Sheldon RA, Vexler ZS, Ferriero DM, Weinstein PR, Liu J. Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke. 2006;37:507–512. doi: 10.1161/01.STR.0000199057.00365.20. [DOI] [PubMed] [Google Scholar]
- 106.Sheppard PW, Sun X, Khammash M, Giffard RG. Overexpression of heat shock protein 72 attenuates NF-κB activation using a combination of regulatory mechanisms in microglia. PLoS Comput Biol. 2014;10:e1003471. doi: 10.1371/journal.pcbi.1003471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Xu H, Sun H, Chen SH, Zhang YM, Piao YL, Gao Y. Effects of acupuncture at baihui (DU20) and zusanli (ST36) on the expression of heat shock protein 70 and tumor necrosis factor α in the peripheral serum of cerebral ischemia-reperfusion-injured rats. Chin J Integr Med. 2014;20:369–374. doi: 10.1007/s11655-014-1800-z. [DOI] [PubMed] [Google Scholar]
- 108.Sun N, Shi J, Chen L, Liu X, Guan X. Influence of electroacupuncture on the mRNA of heat shock protein 70 and 90 in brain after cerebral ischemia/reperfusion of rats. J Huazhong Univ Sci Technolog Med Sci. 2003;23:112–115. doi: 10.1007/BF02859930. [DOI] [PubMed] [Google Scholar]
- 109.Yan XY. Effect of electroacupuncture on free radical content and HSP70 expression in the brain tissue in rats with cerebral ischemia-reperfusion injury. Zhen Ci Yan Jiu. 2007;32:102–104. [PubMed] [Google Scholar]
- 110.Shi P, Sun LL, Lee YS, Tu Y. Electroacupuncture regulates the stress-injury-repair chain of events after cerebral ischemia/reperfusion injury. Neural Regen Res. 2017;12:925–930. doi: 10.4103/1673-5374.208574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Zheng JY, Zhu J, Wang Y, Tian ZZ. Effects of acupuncture on hypothalamic-pituitary-adrenal axis: current status and future perspectives. J Integr Med. 2024;22:445–458. doi: 10.1016/j.joim.2024.06.004. [DOI] [PubMed] [Google Scholar]
- 112.Wei Y, Ma Z, Xu N, He Y, Cao M, Wang L. Investigating the antidepressant mechanism of acupuncture with a focus on mitochondrial homeostasis. Int J Gen Med. 2026;19:584012. doi: 10.2147/IJGM.S584012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Liang MT, Li GC, Zhu H, Gong Q, Dong KL, Long C, Li YY, Sayrash J. Effect of acupuncture on hippocampal mitochondrial proteome expression in SAMP8 mouse model with alzheimer disease. Journal of Acupuncture and Tuina Science. 2018;16:67–79. [Google Scholar]
- 114.Kalmar B, Greensmith L. Cellular chaperones as therapeutic targets in ALS to restore protein homeostasis and improve cellular function. Front Mol Neurosci. 2017;10:251. doi: 10.3389/fnmol.2017.00251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Liu XW, Yan Y, Hei YF, Zhu CJ, Tian Q, Sun WJ. Effect of electroacupuncture on expression of heat shock protein 70 in mice with amyotrophic lateral sclerosis. Zhen Ci Yan Jiu. 2021;46:391–396. doi: 10.13702/j.1000-0607.200639. [DOI] [PubMed] [Google Scholar]
- 116.Wang SJ, Zhang JJ, Qie LL. Acupuncture relieves the excessive excitation of hypothalamic-pituitary-adrenal cortex axis function and correlates with the regulatory mechanism of GR, CRH, and ACTHR. Evid Based Complement Alternat Med. 2014;2014:495379. doi: 10.1155/2014/495379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Wu F, Zhu J, Wan Y, Subinuer Kurexi, Zhou J, Wang K, Chen T. Electroacupuncture ameliorates hypothalamic-pituitary-adrenal axis dysfunction induced by surgical trauma in mice through the hypothalamic oxytocin system. Neurochem Res. 2023;48:3391–3401. doi: 10.1007/s11064-023-03984-y. [DOI] [PubMed] [Google Scholar]
- 118.Wang RY, Noddings CM, Kirschke E, Myasnikov AG, Johnson JL, Agard DA. Structure of Hsp90-Hsp70-Hop-GR reveals the Hsp90 client-loading mechanism. Nature. 2022;601:460–464. doi: 10.1038/s41586-021-04252-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.An HJ, Lee JH, Lee HJ, Yang WM, Park SK, Hong SH, Kim HM, Um JY. Electroacupuncture protects against CCK-induced acute pancreatitis in rats. NeuroImmunomodulation. 2007;14:112–118. doi: 10.1159/000107793. [DOI] [PubMed] [Google Scholar]
- 120.Tan CF, Yan J, Wang C, Chang XR, Xie WJ, Yang JJ, Liu M, Lin HB, He XC. Effects of electroacupuncture and moxibustion pretreatment on expressions of HSP 27, HSP 70, HSP 90 at different time-points in rabbits with myocardial ischemia-reperfusion injury. Zhen Ci Yan Jiu. 2017;42:31–38. [PubMed] [Google Scholar]
- 121.Zhu W, Wang XR, Du SQ, Yan CQ, Yang NN, Lin LL, Shi GX, Liu CZ. Anti-oxidative and anti-apoptotic effects of acupuncture: role of thioredoxin-1 in the hippocampus of vascular dementia rats. Neuroscience. 2018;379:281–291. doi: 10.1016/j.neuroscience.2018.03.029. [DOI] [PubMed] [Google Scholar]
- 122.Liu ZZ, Huang W, Xiang LL, Yang QQ, Xue YX, Wu S, Li J. Effect of electroacupuncture preconditioning on myocyte apoptosis in myocardial ischemia-reperfusion injury rats based on FXR/SHP pathway. Zhen Ci Yan Jiu. 2021;46:368–374. doi: 10.13702/j.1000-0607.200617. [DOI] [PubMed] [Google Scholar]
- 123.Tiefensee Ribeiro C, Peixoto DO, Santos L, Saibro-Girardi C, Brum PO, Carazza-Kessler FG, Somensi N, Behrens LMP, Bittencourt RR, Soares LS, Silveira AK, de Oliveira J, Moreira JCF, Gasparotto J, Gelain DP. Intranasal HSP70 administration protects against dopaminergic denervation and modulates neuroinflammatory response in the 6-OHDA rat model. Brain Behav Immun Health. 2021;14:100253. doi: 10.1016/j.bbih.2021.100253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Dvoriantchikova G, Santos AR, Saeed AM, Dvoriantchikova X, Ivanov D. Putative role of protein kinase C in neurotoxic inflammation mediated by extracellular heat shock protein 70 after ischemia-reperfusion. J Neuroinflammation. 2014;11:81. doi: 10.1186/1742-2094-11-81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Somensi N, Brum PO, de Miranda Ramos V, Gasparotto J, Zanotto-Filho A, Rostirolla DC, da Silva Morrone M, Moreira JCF, Pens Gelain D. Extracellular HSP70 Activates ERK1/2, NF-kB and pro-inflammatory gene transcription through binding with RAGE in A549 human lung cancer cells. Cell Physiol Biochem. 2017;42:2507–2522. doi: 10.1159/000480213. [DOI] [PubMed] [Google Scholar]
- 126.Fan YX, Qian C, Liu B, Wang C, Liu H, Pan X, Teng P, Hu L, Zhang G, Han Y, Yang M, Wu XF, Liu WT. Induction of suppressor of cytokine signaling 3 via HSF-1-HSP70-TLR4 axis attenuates neuroinflammation and ameliorates postoperative pain. Brain Behav Immun. 2018;68:111–122. doi: 10.1016/j.bbi.2017.10.006. [DOI] [PubMed] [Google Scholar]
- 127.Lyu Z, Guo Y, Gong Y, Fan W, Dou B, Li N, Wang S, Xu Y, Liu Y, Chen B, Guo Y, Xu Z, Lin X. The role of neuroglial crosstalk and synaptic plasticity-mediated central sensitization in acupuncture analgesia. Neural Plast. 2021;2021:8881557. doi: 10.1155/2021/8881557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Xu ZF, Gong YN, Dou BM, Fan ZZ, Zhang Y. Current situation and prospect of researches on regularities and mechanisms of acupuncture-moxibustion in alleviating chronic inflammatory response. Zhen Ci Yan Jiu. 2023;48:111–117. doi: 10.13702/j.1000-0607.20221095. [DOI] [PubMed] [Google Scholar]
- 129.Kuang H, Zhu X, Chen H, Tang H, Zhao H. The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction. Front Immunol. 2024;15:1319863. doi: 10.3389/fimmu.2024.1319863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Haidar MA, Ibeh S, Shakkour Z, Reslan MA, Nwaiwu J, Moqidem YA, Sader G, Nickles RG, Babale I, Jaffa AA, Salama M, Shaito A, Kobeissy F. Crosstalk between microglia and neurons in neurotrauma: an overview of the underlying mechanisms. Curr Neuropharmacol. 2022;20:2050–2065. doi: 10.2174/1570159X19666211202123322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Cavalcanti RR, Almeida FM, Martinez AMB, Freria CM. Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury. Front Immunol. 2025;16:1670650. doi: 10.3389/fimmu.2025.1670650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Liu X, Wen S, Yan F, Liu K, Liu L, Wang L, Zhao S, Ji X. Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia. J Neuroinflammation. 2018;15:39. doi: 10.1186/s12974-018-1081-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Xu B, Wang J, Liu S, Liu H, Zhang X, Shi J, Ji L, Li J. HSP70 alleviates spinal cord injury by activating the NF-kB pathway. J Musculoskelet Neuronal Interact. 2021;21:542–549. [PMC free article] [PubMed] [Google Scholar]
- 134.Li H, Yang J, Wang Y, Liu Q, Cheng J, Wang F. Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson’s disease model by inhibition of NF-κB and STAT3. Life Sci. 2019;234:116747. doi: 10.1016/j.lfs.2019.116747. [DOI] [PubMed] [Google Scholar]
- 135.Allaman I, Bélanger M, Magistretti PJ. Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci. 2011;34:76–87. doi: 10.1016/j.tins.2010.12.001. [DOI] [PubMed] [Google Scholar]
- 136.Gleixner AM, Posimo JM, Pant DB, Henderson MP, Leak RK. Astrocytes surviving severe stress can still protect neighboring neurons from proteotoxic injury. Mol Neurobiol. 2016;53:4939–4960. doi: 10.1007/s12035-015-9427-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Yu WW, Cao SN, Zang CX, Wang L, Yang HY, Bao XQ, Zhang D. Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes. Mol Cell Neurosci. 2018;86:58–64. doi: 10.1016/j.mcn.2017.11.013. [DOI] [PubMed] [Google Scholar]
- 138.Kim JY, Yenari MA, Lee JE. Regulation of inflammatory transcription factors by heat shock protein 70 in primary cultured astrocytes exposed to oxygen-glucose deprivation. Neuroscience. 2015;286:272–280. doi: 10.1016/j.neuroscience.2014.11.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Lancaster GI, Febbraio MA. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem. 2005;280:23349–23355. doi: 10.1074/jbc.M502017200. [DOI] [PubMed] [Google Scholar]
- 140.Tytell M. Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues. Int J Hyperthermia. 2005;21:445–455. doi: 10.1080/02656730500041921. [DOI] [PubMed] [Google Scholar]
- 141.Huang Z, Lu T, Liu X, Zhang Z, Song Y, Li Y, Xu W, Zhang X, Ni G. Acupuncture alleviates blood-brain barrier damage after delayed rtPA thrombolysis for acute ischemic stroke by regulating ferroptosis. Brain Behav. 2025;15:e70644. doi: 10.1002/brb3.70644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Stocki P, Wang XN, Dickinson AM. Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells. J Biol Chem. 2012;287:12387–12394. doi: 10.1074/jbc.M111.307579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Qiuping L, Pan P, Zhenzhen L, Zhen Z, Xuezhu Z, Shuting L. Acupuncture regulates the Th17/Treg balance and improves cognitive deficits in a rat model of vascular dementia. Heliyon. 2023;9:e13346. doi: 10.1016/j.heliyon.2023.e13346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Cao BQ, Tan F, Zhan J, Lai PH. Mechanism underlying treatment of ischemic stroke using acupuncture: transmission and regulation. Neural Regen Res. 2021;16:944–954. doi: 10.4103/1673-5374.297061. [DOI] [PMC free article] [PubMed] [Google Scholar]



